TR199800648A1 - Iki veya daha fazla etken madde için ilaç verme sistemi. - Google Patents

Iki veya daha fazla etken madde için ilaç verme sistemi.

Info

Publication number
TR199800648A1
TR199800648A1 TR1998/00648A TR9800648A TR199800648A1 TR 199800648 A1 TR199800648 A1 TR 199800648A1 TR 1998/00648 A TR1998/00648 A TR 1998/00648A TR 9800648 A TR9800648 A TR 9800648A TR 199800648 A1 TR199800648 A1 TR 199800648A1
Authority
TR
Turkey
Prior art keywords
progestogenic
delivery system
drug delivery
active ingredients
thermoplastic polymer
Prior art date
Application number
TR1998/00648A
Other languages
English (en)
Inventor
Johannes Joseph Groenewegen Rudolf
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199800648(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR199800648A1 publication Critical patent/TR199800648A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu bulus vajinal uygulamaya yönelik olarak, progestojenik bir steroid bilesigin ve östrojenik bir steroid bilesigin uzun bir süre sabit bir fizyolojik oranda eszamanli salinimi için kullanilan tercihen halka biçiminde bir ilaç verme sistemine iliskindir. Ilaç verme sistemi progestojenik ve östrojenik bilesikleri içeren termoplastik bir polimer çekirdek ve termoplastik bir polimer kabuktan olusur; progestojenik bilesik baslangiçta nispeten düsük bir asiridoyma derecesinde polimer çekirdek malzemesinde eritilir.
TR1998/00648A 1997-04-11 1998-04-03 Iki veya daha fazla etken madde için ilaç verme sistemi. TR199800648A1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201098 1997-04-11

Publications (1)

Publication Number Publication Date
TR199800648A1 true TR199800648A1 (tr) 1998-10-21

Family

ID=8228203

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00648A TR199800648A1 (tr) 1997-04-11 1998-04-03 Iki veya daha fazla etken madde için ilaç verme sistemi.

Country Status (27)

Country Link
US (1) US5989581A (tr)
EP (1) EP0876815B1 (tr)
JP (2) JP4982670B2 (tr)
KR (1) KR100492676B1 (tr)
CN (1) CN1163222C (tr)
AR (1) AR011709A1 (tr)
AT (1) ATE211646T1 (tr)
AU (1) AU726934B2 (tr)
BR (1) BR9801027B1 (tr)
CA (1) CA2233753C (tr)
CZ (1) CZ294099B6 (tr)
DE (1) DE69803112T2 (tr)
DK (1) DK0876815T3 (tr)
ES (1) ES2171283T3 (tr)
HK (1) HK1016886A1 (tr)
HU (1) HU222343B1 (tr)
ID (1) ID21259A (tr)
IL (2) IL123813A0 (tr)
NO (1) NO320394B1 (tr)
NZ (1) NZ330145A (tr)
PL (1) PL192449B1 (tr)
PT (1) PT876815E (tr)
RU (1) RU2206325C2 (tr)
SG (1) SG65061A1 (tr)
TR (1) TR199800648A1 (tr)
TW (1) TW358031B (tr)
ZA (1) ZA982911B (tr)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6039968A (en) † 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6361780B1 (en) * 1998-11-12 2002-03-26 Cardiac Pacemakers, Inc. Microporous drug delivery system
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US7369463B1 (en) 2000-02-21 2008-05-06 N.V. Organon Electronic alarm timer for use with a medical regimen
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
US7187980B2 (en) * 2001-11-09 2007-03-06 Oscor Inc. Cardiac lead with steroid eluting ring
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
AU2003234439A1 (en) * 2002-05-07 2003-11-11 Control Delivery Systems, Inc. Processes for forming a drug delivery device
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
KR20050072812A (ko) 2002-11-07 2005-07-12 악조 노벨 엔.브이. 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌
US7357046B2 (en) * 2002-12-16 2008-04-15 N. V. Organon Method for dissolution testing of a pharmaceutical delivery device
ES2293084T3 (es) * 2002-12-16 2008-03-16 N.V. Organon Recipiente, metodo y aparato para la prueba de disolucion de un dispositivo de administracion farmaceutica.
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
WO2005070949A1 (en) * 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
EP1709061A1 (en) * 2004-01-15 2006-10-11 Warner Chilcott Company Inc. Di-steroidal prodrugs of ethinyl estradiol
CA2559224C (en) * 2004-03-24 2011-12-13 N.V. Organon Drug delivery system based on polyethylene vinylacetate copolymers
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
WO2006053836A1 (en) * 2004-11-16 2006-05-26 Universite De Liege Active substance delivery system comprising a hydrogel atrix and microcarriers
CN100366242C (zh) * 2005-01-13 2008-02-06 杭州容立医药科技有限公司 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用
JP2009511087A (ja) * 2005-06-20 2009-03-19 アビームーア メディカル インコーポレイテッド 薬剤送達用品、付属用品、およびシステム
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
MX2008000412A (es) * 2005-07-12 2008-03-10 Warner Chilcott Co Inc Profarmacos de 3-ester de estradiol.
US7795241B2 (en) * 2005-07-12 2010-09-14 Warner Chilcott Company, Llc Derivative prodrugs of ethinyl estradiol
CN1899643B (zh) * 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
EP1933810B1 (en) * 2005-08-11 2012-10-10 Massachusetts Institute of Technology Intravesical drug delivery device and method
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
DK2231254T3 (da) 2007-12-11 2014-07-21 Massachusetts Inst Technology Implanterbar lægemiddelafgivelsesindretning
KR101794899B1 (ko) 2008-08-09 2017-11-07 메사츄세츠 인스티튜트 어브 테크놀로지 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US20110280922A1 (en) * 2008-11-07 2011-11-17 Combinent Biomedical Systems, Inc. Devices and methods for treating and/or preventing diseases
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
EP2408423A2 (en) 2009-03-17 2012-01-25 Intervet International B.V. Zoo-technical drug delivery device
MX2011010607A (es) 2009-04-07 2012-04-02 Catholic Healthcare West Sistema y metodo de estimulacion electrica uterina.
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
JP5695035B2 (ja) 2009-06-03 2015-04-01 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 前眼部薬物供給
US10543166B2 (en) 2009-06-26 2020-01-28 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
CN102497855B (zh) 2009-07-21 2013-12-25 人口委员会股份有限公司 多层梯度的阴道环
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
CA2798034A1 (en) * 2010-03-28 2011-10-13 Evestra, Inc. Intravaginal drug delivery device
US20130096092A1 (en) 2010-06-10 2013-04-18 Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US8972028B2 (en) 2010-10-27 2015-03-03 Dignity Health Uterine electrical stimulation system and method
US9872983B2 (en) 2010-10-27 2018-01-23 Dignity Health Uterine electrical stimulation system and method
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
KR101263916B1 (ko) 2011-01-11 2013-05-13 이장희 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법
AU2012211960B2 (en) * 2011-02-04 2016-12-01 Taris Biomedical Llc Implantable device for controlled release of low solubility drug
KR20140074281A (ko) * 2011-07-20 2014-06-17 패트릭 에프. 카이저 약물 전달용 질내 장치
EP2749286B1 (en) 2011-08-26 2017-03-01 Universidad De Santiago De Chile Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process
CA2884030C (en) 2012-09-03 2018-04-10 Ecosea Farming S.A. Reservoir-cage submersion system for the culture and/or containment of hydrobiological species
KR20150085512A (ko) 2012-11-22 2015-07-23 바이엘 파마 악티엔게젤샤프트 필요시 피임을 위한 레보노르게스트렐 및 cox 억제제 함유 제약 조성물의 용도 및 적용 요법
CN105120746A (zh) 2013-03-08 2015-12-02 里加利私人有限公司 阴道给药和/或诊断系统
KR102398262B1 (ko) 2013-03-15 2022-05-13 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치 및 방법
JP6486359B2 (ja) 2013-08-19 2019-03-20 タリス バイオメディカル エルエルシー 多ユニット薬物送達デバイス及び方法
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3277241B1 (en) 2015-03-31 2023-12-20 Merck Sharp & Dohme B.V. Vaginal ring applicator
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
EP3294300A1 (en) * 2015-05-13 2018-03-21 Bayer Oy A long acting drug delivery device and its use in contraception
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
EP3395335A1 (en) 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
DE102017113166A1 (de) * 2017-06-14 2018-12-20 Amw Gmbh Depotform zur Abgabe eines Östrogen-Wirkstoffs
US11103460B2 (en) 2017-08-07 2021-08-31 Board Of Regents, The University Of Texas System Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
JP2021524840A (ja) 2018-05-24 2021-09-16 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス
EP3893884A4 (en) * 2018-12-11 2022-09-14 Lupin Inc. EXTREMELY LOW COMBINATION OF ESTROGEN COMBINATIONS DRUG DELIVERY SYSTEM, AND METHODS AND USES THEREOF
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
CN113164383B (zh) 2019-10-12 2022-08-12 国家卫生健康委科学技术研究所 用于黄体支持的阴道缓释给药系统及其制备方法与应用
JP2023503642A (ja) 2019-11-27 2023-01-31 オーク クレスト インスティテュート オブ サイエンス 徐放性薬物送達デバイス
USD935018S1 (en) 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
WO2023133517A1 (en) 2022-01-06 2023-07-13 Oak Crest Institute Of Science Subdermal implant for sustained drug delivery
WO2024115763A1 (en) 2022-12-02 2024-06-06 Vari Bioscience Gmbh Estriol vaginal ring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
ATE86484T1 (de) * 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
JPH03123727A (ja) * 1989-10-04 1991-05-27 Nitto Denko Corp 経皮吸収製剤
DE69616551T2 (de) * 1995-07-04 2002-05-29 Akzo Nobel Nv Ringförmige vorrichtung
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances

Also Published As

Publication number Publication date
US5989581A (en) 1999-11-23
CA2233753A1 (en) 1998-10-11
DE69803112T2 (de) 2002-07-18
CZ110298A3 (cs) 1998-10-14
JP2009256378A (ja) 2009-11-05
PL192449B1 (pl) 2006-10-31
IL123813A (en) 2001-11-25
HUP9800863A2 (hu) 1999-02-01
AU6075198A (en) 1998-10-15
CZ294099B6 (cs) 2004-10-13
NO320394B1 (no) 2005-11-28
DE69803112D1 (de) 2002-02-14
HK1016886A1 (en) 1999-11-12
CN1163222C (zh) 2004-08-25
KR100492676B1 (ko) 2005-10-19
JP4982670B2 (ja) 2012-07-25
PL325774A1 (en) 1998-10-12
TW358031B (en) 1999-05-11
PT876815E (pt) 2002-07-31
ES2171283T3 (es) 2002-09-01
HUP9800863A3 (en) 2000-06-28
CN1196930A (zh) 1998-10-28
AU726934B2 (en) 2000-11-23
JPH10287549A (ja) 1998-10-27
KR19980081290A (ko) 1998-11-25
NZ330145A (en) 1999-05-28
ATE211646T1 (de) 2002-01-15
HU9800863D0 (en) 1998-05-28
NO981638D0 (no) 1998-04-08
AR011709A1 (es) 2000-08-30
CA2233753C (en) 2001-12-25
IL123813A0 (en) 1998-10-30
BR9801027A (pt) 2000-01-11
BR9801027B1 (pt) 2009-01-13
ID21259A (id) 1999-05-12
DK0876815T3 (da) 2002-04-22
RU2206325C2 (ru) 2003-06-20
EP0876815A1 (en) 1998-11-11
NO981638L (no) 1998-10-12
HU222343B1 (hu) 2003-06-28
ZA982911B (en) 1998-10-09
EP0876815B1 (en) 2002-01-09
SG65061A1 (en) 1999-05-25

Similar Documents

Publication Publication Date Title
TR199800648A1 (tr) Iki veya daha fazla etken madde için ilaç verme sistemi.
HK1042444A1 (zh) 藥用噴霧製劑
GB2305122B (en) Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
AU1227899A (en) Osmotic medicament releasing system
ES8503508A1 (es) Una forma de dosificacion unitaria farmaceutica
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
ES2194989T3 (es) Composicion adminstrada por via oral, que comprende una toxina de zonula occludens y un agente que tiene una actividad biologica, y su utilizacion.
FI932789A0 (fi) Emättimensisäinen antosysteemi
IS6209A (is) Ný blanda
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
EP0888775A3 (en) Control of selective estrogen receptor modulators
NZ511214A (en) Drug delivery device, especially for the delivery of androgens
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
EP1090639A3 (en) Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
AU2502301A (en) Medicament and combination of compatible medicaments